ArticleExperimental and therapeutic medicine2024
Apatinib beyond first progression is associated with prolonged overall survival in patients with advanced breast cancer: Results from an observational study.
Jing Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.